Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$311K Hold
2,139
– – 0.23% 73
2026
Q2
$275K Buy
2,139
+200
+10% +$23.4K 0.21% 81
2026
Q1
$233K Sell
1,939
-38
-2% -$4.39K 0.2% 85
2025
Q4
$208K Buy
+1,977
New +$186K 0.18% 93

Other funds holding MRK

Bayban's MRK Position: Q3 2026 in Review

Bayban held its Merck (MRK) position steady in Q3 2026 at 2,139 shares worth $311K. The position accounts for 0.23% of the portfolio, ranked #73.

Bayban first reported a position in MRK in Q4 2025 and has held it in 4 quarters since. 3,974 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Bayban held 2,139 shares of Merck worth $311K as of Q3 2026.
  • Bayban left its Merck share count unchanged in Q3 2026.
  • Merck made up 0.23% of Bayban's portfolio in Q3 2026, its #73 holding.
  • Bayban first reported a position in Merck in Q4 2025 and has held it in 4 quarters since.
  • 3,974 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.